Trial Profile
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2021
Price :
$35
*
At a glance
- Drugs Riboflavin (Primary)
- Indications Corneal disorders
- Focus Therapeutic Use
- Sponsors Avedro
- 12 Jun 2014 New trial record